FOR IMMEDIATE RELEASE
December 10, 2025

Geistlich Enters a Manufacturing and Supply Partnership with Meisinger

PRINCETON, NJ — Geistlich Pharma North America is pleased to announce the launch of the Meisinger Screws and the Meisinger Screw System TX. Meisinger is a globally recognized leader in dental surgical instruments. Founded in 1888, Meisinger has over 135 years of precision German manufacturing. They are known for combining innovation with reliability and offer fixation solutions that are trusted by clinicians worldwide.

The Meisinger Screw System TX is an all-purpose screw system for simple and safe fixation of bone segments. The unique Torx connection guarantees reliable accommodation of the screws in the screwdriver and allows for the transfer of high tensile forces. A large diameter rescue screw is also included should high tensile fixation is not possible.

The Meisinger Screws enable the universal use of fixation for autogenous bone cylinders, bone blocks, and bone shells for pre-implant augmentation procedures, and can also be used to securely fixate Yxoss CBR® meshes for precise scaffold stabilization. The screw thread goes up to the head of the screws which allows for the sandwich or bone shell augmentation. The small diameter and the low head size of the screws allow for a comfortable application for patient and user.

“We are excited to partner with Meisinger, a company that shares our commitment to precision, clinical excellence, and education,” said Les Burrows, General Manager, Geistlich Pharma North America. “This partnership strengthens our portfolio, especially with our product Yxoss CBR® by combining Geistlich’s regenerative expertise with the confidence and reliability of the Meisinger Screws and Screw System TX, supporting clinicians in even the most complex bone regeneration cases.”

FOR IMMEDIATE RELEASE

PRINCETON, NJ — Geistlich is presenting Geistlich Bio-Gide® Forte, a new membrane based on proven collagen technology. It offers greater strength, is easy to handle, and adapts to the ridge contour. The resorbable membrane will be unveiled at the annual meeting of the American Academy of Periodontology (AAP). 

Geistlich continuously expands its product portfolio to provide clinicians and patients worldwide with even more regenerative solutions. The family-owned company is launching Geistlich Bio-Gide® Forte, an advanced collagen membrane that supports reliable bone regeneration and optimal tissue integration. With its differentiated handling properties and high tensile strength, Geistlich Bio-Gide® Forte is designed for use in a wide range of bone and soft tissue regeneration cases.^1,2

Proven Geistlich Bio-Gide® technology with added strength
Mark Spilker, Chief Science Officer at Geistlich, says: “With Geistlich Bio-Gide® Forte, we are expanding our membrane portfolio by offering a version of Geistlich Bio-Gide® that delivers particularly robust handling.” Geistlich Bio-Gide® Forte is particularly firm and stable when hydrated. The membrane unfolds easily, can be cut even when hydrated, and enables tailoring to defect size and shape, providing precise adaptation and optimal coverage .¹ Building on the excellent properties of Geistlich Bio-Gide® technology, the new product also helps to improve the survival rate of implants.³

More information about Geistlich Bio-Gide® Forte

What an unforgettable week at ISPRD! We were thrilled to connect with so many leading dental professionals and share our latest innovations in regenerative dentistry. The energy, visibility, and engagement at the meeting were incredible, and we hope this recap gives you a sense of the momentum and experience we created as a team there!

The Geistlich Corporate Forum was a resounding success, featuring a stellar lineup of experts who shared invaluable insights into the future of dental regeneration. The Corporate Forum included an all-star lineup of clinicians from around the world! Doctors Kurmar, Schallhorn, Rocchietta, and Urban delivered outstanding lectures on the Geistlich full portfolio.

Following the corporate forum, the Geistlich All-Access Lounge debuted across from the booth and was packed all weekend. For a more informal and interactive experience, our All-Access Lounge was the ideal spot. With a “Rockstar-Level Experience” theme, attendees had the opportunity for hands-on demonstrations of our new products and scored some exclusive Geistlich swag. Clinicians stopped by for Yxoss® and Micross Curve product demos, exclusive swag, and daily “Regenerate Yourself” snack breaks. Our custom scrub cap printing was a showstopper—people lined up daily, and we completely sold out in just 1.5 days!

Of course, we can’t forget to mention our hugely successful networking event with our partners from the Osteology Foundation. This event drew over 100 doctors from around the United States. Hosted in the hotel’s main lobby restaurant with a live DJ, our networking event was the place to be in Boston for both younger and veteran clinicians.

We extend a sincere “thank you” to the organizers of ISPRD for putting on an exceptional symposium. And to everyone who stopped by our booth, attended our events, and shared your passion with us – you made this a truly memorable week. We are already looking forward to the next opportunity to connect and continue to shape the future of regenerative dentistry together!

FOR IMMEDIATE RELEASE
June 12, 2025

Geistlich Expands Innovative Product Portfolio with Launch of Micross Curve

PRINCETON, NJ — Geistlich Pharma North America is proud to announce the launch of the Micross Curve, the latest innovation with META and the newest addition to the trusted META Family of regenerative tools.

Geistlich wants to expand the treatment spectrum of its regenerative products through in-house developments, acquisitions and partnerships and make it accessible to an even larger group of patients. One example of this is the medical technology company Meta Technologies s.r.l., which has been part of Geistlich since 2021. Its instruments are considered the gold standard in dentistry. 

Engineered for enhanced precision and ease of use, the Micross Curve is designed to advance the field of minimally invasive bone harvesting. Building on the proven success of the original Micross, the Micross Curve incorporates a bent, micro-sized blade based on Safescraper® Twist technology—making it one-third smaller than the original Safescraper blade while retaining its key benefits.

Featuring a slim, ergonomic design, the Micross Curve is ideal for use in narrow or hard-to-reach anatomical sites. Its curved tip ensures optimal visibility and comfort during clinical procedures, enabling clinicians to access challenging areas with improved control and handling.

“We are excited to bring the Micross Curve to market as we continue our commitment to providing advanced regenerative solutions,” said Les Burrows, General Manager, Geistlich Pharma North America. “This addition represents another step forward in supporting clinicians with tools designed for precision, safety, and efficiency.”

To learn more about the Micross Curve or explore Geistlich’s full range of regenerative solutions, visit: https://geistlich.us

Geistlich is proud to announce the launch of Geistlich myGuide®, the world’s first complete online learning journey in regenerative dentistry. This enables clinical professionals to learn from leading experts in the field of dental regeneration and to continuously educate themselves regardless of time and place.

Sharing expertise in the field of medical regeneration is deeply rooted in Geistlich’s DNA. From experience, the Swiss manufacturer of Geistlich Bio-Oss^® and Geistlich Bio-Gide^® knows that about 80 percent of the questions related to implant treatments concern regeneration.

Previous training courses in this area have mostly included individual lectures, hands-on workshops, or webinars. However, structured online learning offers have hardly existed to date. Geistlich wants to close this gap with Geistlich myGuide^®.

A pioneering offer for regenerative dentistry

With Geistlich myGuide^®, clinical professionals from around the world will have the opportunity to learn from the best clinicians and scientists in the field of dental regeneration. A total of 27 internationally renowned experts have created the content. The scientific partner for Geistlich myGuide^® is Prof. Dr. Ronald E. Jung from the University of Zurich. Under his guidance, the structure, scope, and learning objectives of this learning journey have been created.

“Geistlich myGuide^® is a highly innovative development that takes regenerative dentistry education to the next level. Geistlich myGuide^® puts patients first and offers regenerative solutions for all indications.” Prof. Dr. Ronald E. Jung, Director Clinic of Reconstructive Dentistry, University of Zurich

All course content builds on each other, ensuring a structured learning process. At the same time, Geistlich myGuide^® is very much geared to everyday clinical practice. Pure theory modules have been deliberately avoided.

Wide range of practice-oriented learning content

Five different learning formats are used: so-called e-learning modules that are 100 percent responsive. This means that learning is possible without restrictions on all mobile devices. In addition, uncut clinical videos, clinical case documentation, hands-on courses in the form of online workshops conducted from home, and, of course, assessment modules for a knowledge check are integrated.

Dr. Andreas Geistlich, Chairman of the Board of Directors at Geistlich, says: “Supporting the dental community and ensuring the best possible care for patients is part of Geistlich’s DNA. With the introduction of this innovative educational journey, we are opening new perspectives for continuing education in dentistry. I am impressed!”

Clinical professionals from around the world are invited to join this educational journey and actively shape the future of regenerative dentistry.

Learn more about this new offering in regenerative dentistry and start your learning journey today at www.geistlich-myguide.com. This educational offering is initially available in English. However, other language versions are planned in the medium term.

April 9, 2024

Geistlich Pharma North America announced today the launch of Reoss’s latest innovation, Yxoss CBR® Fully Protect, the newest addition to the Yxoss CBR® Family!

Now there are three Yxoss CBR® options to best suit your needs: Yxoss CBR® Classic, Yxoss CBR® Protect, and now Yxoss CBR® Fully Protect! The new Yxoss CBR® Fully Protect has the same characteristics as the other configurations: 3D-printed custom-made titanium mesh that accurately reflects specific patient data, provides a solution for both vertical and horizontal ridge augmentation procedures, and gives the opportunity for integrated implant positioning.

In addition, Yxoss CBR® Fully Protect maintains the same established benefits of the Yxoss CBR® family: removes time-consuming, cutting, shaping, and adapting titanium mesh, gives the opportunity to reduce surgery time due to perfect fit without complex adaptations, and eliminates sharp edges and challenging removal which inhibits proper healing. The easy removal design allows for all Yxoss CBR® products to be removed easily with pre-defined breaking points.

For complex bone defects, needs will vary based on the position and extent of the defect, the patient’s anatomy, overall treatment requirements, and personal preference. The benefit of Yxoss CBR® Fully Protect is its fully microstructured surface that protects from tissue ingrowth. Having a dense microstructure across the complete scaffold allows for high stability and space maintenance, very easy removal, and enables good bone maturation due to a very well-vascularized tissue.

For more information about Yxoss CBR® Fully Protect and to stay updated on the latest news and offers from Geistlich, please visit https://geistlich.us/

March 20, 2024

Geistlich Pharma North America announced today the launch of its latest innovation with META, the SafeScraper TWIST VOLUMIZER, the newest addition to the SafeScraper Family!

The new SafeScraper Twist VOLUMIZER provides the established benefits of the proven SAFESCRAPER TWIST curve: it provides an easy method for harvesting autogenous cortical bone for use in grafted sites with a minimally invasive technique.

Due to the exceptional functionality of the instrument, the ergonomic design provides excellent control during the harvesting procedure. The curved tip of the instrument facilitates easy access to donor sites, which makes it ideal for both minor and major harvesting procedures.

The SafeScraper Twist VOLUMIZER is the extra volume version of the SafeScraper Twist; it offers the same performance of rapid and accurate collection of autologous cortical bone, while collecting a larger bone volume.

This product has a redesigned blade with double grooves that allow for three collecting surfaces. The cutting performance reduces patient discomfort, and the quality of harvested bone for use in grafted sites promotes graft acceptance, neovascularization, and bone regeneration. ^1,2

For more information about the SafeScraper TWIST VOLUMIZER and to stay updated on the latest news and offers from Geistlich, please visit https://geistlich.us/

December 07, 2023

Geistlich Pharma North America, Inc. proudly announces the successful conclusion of the 11th annual Philip J. Boyne Scholarship Award. This prestigious scholarship, born out of the shared enthusiasm for innovation and bone regeneration between Dr. Philip J. Boyne and Dr. Peter Geistlich, continues to make a lasting impact on the field. The scholarship, established to honor the memory and collaborative spirit of these two pioneers, recognizes and supports residents who embody their commitment to advancing oral and maxillofacial surgery.

Honoring a Legacy:

The friendship between Dr. Philip J. Boyne and Dr. Peter Geistlich laid the foundation for groundbreaking developments in the field, culminating in the creation of Geistlich Bio-Oss®. To pay tribute to their enduring legacy, Geistlich Pharma North America, Inc. established the Philip J. Boyne Scholarship, an initiative that serves as a beacon for aspiring professionals who share the same spirit of innovation.

A Decade of Support and Empowerment:

Since its inception in 2011, the Philip J. Boyne Scholarship has empowered hundreds of residents from Oral and Maxillofacial Surgery (OMS) Programs across the country. These aspiring professionals have been given the invaluable opportunity to participate in the AAOMS Dental Implant Conference held annually in Chicago. This exposure to cutting-edge research, techniques, and networking has played a role in shaping the future of oral and maxillofacial surgery.

Commitment to Excellence:

This year, the commitment to excellence and the advancement of the field reached new heights, with scholarships awarded to 40 residents. Geistlich Pharma North America, Inc. continues to demonstrate its dedication to fostering the next generation of leaders and innovators.

Recognition and Celebration:

The culmination of this year’s scholarship program was celebrated at the annual cocktail reception on November 30, 2023, at the Sheraton Grand Hotel, Chicago, coinciding with the AAOMS Dental Implant Conference. This event provided a platform to recognize the outstanding achievements of the scholarship recipients, creating an atmosphere of camaraderie and collaboration among professionals in the field.

December 01, 2023

Geistlich Pharma AG has appointed Diego Gabathuler as its new CEO, effective December 1, 2023. He succeeds Ralf Halbach, who departed the company in August 2023.  

Diego Gabathuler is a 49-year-old Swiss National who brings a broad range of experience from various management positions as well as extensive knowledge in business development and strategic marketing.

Most recently, he was CEO of the dental company Ivoclar. He has expertise in the MedTech sector, excellent leadership qualities, and a proven strategic acumen. His professional career also includes management positions at international digital-tech companies such as Logitech, Activision, and Electronic Arts.  

Andreas Geistlich, Chairman of the Board of Directors, who held the CEO position on an interim basis: “The Geistlich strategic plan includes further investment in new products, solutions, and technologies in order to apply regenerative medicine in helping even more people around the world. We are convinced that Diego Gabathuler’s expertise will support us significantly in this mission.”  

Geistlich wishes Diego a successful start, and we look forward to working with him to further advance the future of regenerative medicine. 

For Immediate Release:

­­­PRINCETON, N.J. October 2, 2023 – Geistlich Pharma North America Inc. is pleased to announce that our Executive Chairman, Dr. Andreas Geistlich, has been awarded the prestigious American Association of Oral and Maxillofacial Surgeons (AAOMS) Board of Trustees Special Citation Award for the company’s exceptional and longstanding contributions to the field of Oral and Maxillofacial Surgery.

The Special Citation Award was presented to Dr. Andreas Geistlich, at the 105th Annual AAOMS Meeting Opening Awards Ceremony on September 20, 2023, in San Diego, CA. The event brought together leaders, professionals, and enthusiasts from the Oral and Maxillofacial community to celebrate his remarkable achievements and contributions.

For Immediate Release:

Princeton, New Jersey October 26, 2022: Geistlich Pharma North America announced today the acquisition of Lynch Biologics, LLC, the developer, and sole provider of GEM 21S^®, the first recombinant growth factor product for use in oral regenerative surgery. This acquisition further strengthens the regenerative product portfolio of Geistlich and provides significant growth potential.

Following the close of this acquisition, as a member of the Geistlich team Dr. Lynch will continue to support Lynch Biologic customers through best-in-class dental education and trainings, as well as assist in addressing any questions doctors may have regarding GEM 21S®.  In addition, we’re seamlessly integrating our operations, so all of Lynch Biologic customers can continue to order GEM 21S® online, call the same 1-800 number, and most importantly, continue to get the same personalized service.